CNO Financial Group, Inc. (NYSE:CNO - Get Free Report) insider Yvonne K. Franzese sold 2,097 shares of the business's stock in a transaction dated Wednesday, March 26th. The stock was sold at an average price of $42.56, for a total transaction of $89,248.32. Following the sale, the insider now directly owns 30,321 shares in the company, valued at approximately $1,290,461.76. This represents a 6.47 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
CNO Financial Group Trading Down 1.9 %
Shares of CNO traded down $0.81 on Friday, hitting $41.46. 704,562 shares of the stock traded hands, compared to its average volume of 706,293. CNO Financial Group, Inc. has a 1 year low of $24.92 and a 1 year high of $43.20. The stock's 50 day moving average is $40.45 and its two-hundred day moving average is $38.10. The firm has a market capitalization of $4.16 billion, a P/E ratio of 11.09 and a beta of 1.02. The company has a quick ratio of 0.19, a current ratio of 0.22 and a debt-to-equity ratio of 1.61.
CNO Financial Group (NYSE:CNO - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The financial services provider reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.06 by $0.25. CNO Financial Group had a return on equity of 17.20% and a net margin of 9.08%. As a group, sell-side analysts predict that CNO Financial Group, Inc. will post 3.83 earnings per share for the current year.
CNO Financial Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Monday, March 24th. Investors of record on Monday, March 10th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $0.64 annualized dividend and a yield of 1.54%. CNO Financial Group's dividend payout ratio (DPR) is presently 17.11%.
Institutional Trading of CNO Financial Group
A number of hedge funds have recently added to or reduced their stakes in CNO. GAMMA Investing LLC lifted its holdings in shares of CNO Financial Group by 15.3% during the 4th quarter. GAMMA Investing LLC now owns 2,289 shares of the financial services provider's stock worth $85,000 after acquiring an additional 304 shares during the period. Principal Securities Inc. increased its position in CNO Financial Group by 51.6% during the fourth quarter. Principal Securities Inc. now owns 955 shares of the financial services provider's stock worth $36,000 after purchasing an additional 325 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in CNO Financial Group by 1.7% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 22,647 shares of the financial services provider's stock worth $795,000 after purchasing an additional 376 shares during the period. Mariner LLC boosted its holdings in shares of CNO Financial Group by 6.7% in the 4th quarter. Mariner LLC now owns 6,116 shares of the financial services provider's stock valued at $228,000 after purchasing an additional 385 shares during the last quarter. Finally, HighTower Advisors LLC grew its stake in shares of CNO Financial Group by 5.3% during the 4th quarter. HighTower Advisors LLC now owns 7,873 shares of the financial services provider's stock valued at $293,000 after buying an additional 394 shares during the period. 95.43% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on CNO shares. Keefe, Bruyette & Woods lifted their price target on shares of CNO Financial Group from $42.00 to $44.00 and gave the company a "market perform" rating in a research report on Wednesday, February 12th. BMO Capital Markets initiated coverage on shares of CNO Financial Group in a report on Thursday, January 23rd. They set a "market perform" rating and a $38.00 target price for the company. Royal Bank of Canada raised their price objective on shares of CNO Financial Group from $40.00 to $45.00 and gave the stock an "outperform" rating in a research note on Monday, February 10th. Jefferies Financial Group upped their target price on CNO Financial Group from $36.00 to $41.00 and gave the company a "hold" rating in a research note on Tuesday, December 10th. Finally, Piper Sandler reissued an "overweight" rating and set a $46.00 price target (up previously from $44.00) on shares of CNO Financial Group in a research report on Monday, February 10th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $40.50.
Check Out Our Latest Report on CNO
About CNO Financial Group
(
Get Free Report)
CNO Financial Group, Inc, through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, insurance products, and financial services for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face.
Further Reading

Before you consider CNO Financial Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CNO Financial Group wasn't on the list.
While CNO Financial Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.